The institute, which specializes in structural biology research that is key to understanding and treating disease, will now ...

Wells Fargo lowered the firm’s price target on Woodward (WWD) to $193 from $197 and keeps an Equal Weight rating on the shares. The firm’s ...

WASHINGTON, Jan 4 (Reuters) - Donald Trump on Saturday named Stanley Woodward, an attorney who has defended several of the incoming president's top aides and associates as well as people charged ...

Key Insights Woodward's estimated fair value is US$227 based on 2 Stage Free Cash Flow to Equity Woodward's US$168... WWD will acquire Safran's actuation business in North America, boosting ...

In a report released today, Jason Gerberry from Bank of America Securities maintained a Buy rating on Catalyst Pharma (CPRX – Research Report), ...

Now, Pfizer and the trade group the Pharmaceutical Research and Manufacturers of America (PhRMA) rank among the organizations that have helped Trump raise a record-setting $150 million in pledges ...

Healthcare environments require effective decontamination procedures. These areas differ in layout, heating, ventilation, air conditioning (HVAC), engineering controls, and room classification ...

COPENHAGEN, Denmark, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in the 43rd Annual J.P. Morgan Healthcare ...

Perform material- and labor-effective extrusion with Thermo Scientific™ Pharma 11 Twin-screw Extruder, which requires only a small amount of active pharmaceutical ingredient, operating at ...

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

In the life sciences industry in particular, leading pharma companies are already deploying this technology across their own operations to spur productivity and efficiency for mundane, time ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...